Skip to main content

Table 2 Patient-psychiatrist conversations about LAIs

From: Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia

LAI patient status/conversations, n (%)

Patients on oral antipsychotics

Patients on LAIs

 

(n = 22)

(n = 38)

 Previously treated with LAIa

3 (14)

NA

  Discussion of oral treatment

3

NA

  Discussion of LAI treatment

3

NA

 Oral with discussion of LAI

8 (36)

NA

  Discussion of oral treatment

8

NA

  Discussion of LAI treatment

8

NA

 No discussion of LAI

11 (50)

NA

  Discussion of oral treatment

11

NA

  Discussion of LAI treatment

0

NA

 LAI discontinuation

NA

1 (3)

  Discussion of oral treatment

NA

1

  Discussion of LAI treatment

NA

1

 LAI restart

NA

2 (5)

  Discussion of oral treatment

NA

2

  Discussion of LAI treatment

NA

2

 LAI-to-LAI switch

NA

3 (8)

  Discussion of oral treatment

NA

3

  Discussion of LAI treatment

NA

3

 New start on LAI

NA

11 (29)

  Discussion of oral treatment

NA

9

  Discussion of LAI treatment

NA

11

 LAI continuation

NA

21 (55)

  Discussion of oral treatment

NA

13

  Discussion of LAI treatment

NA

21

LAIs used in treatment, n (%)

  First-generation LAIs

NA

8 (21)

  Second-generation LAIs

NA

30 (79)

  1. a Discussion of history of LAI use, not restarting LAI treatment.
  2. LAI, long-acting injectable antipsychotic.